Journal of International Oncology ›› 2024, Vol. 51 ›› Issue (12): 755-762.doi: 10.3760/cma.j.cn371439-20240910-00128
• Original Articles • Previous Articles Next Articles
Li Tian1,2, Wu Yang2, Zhang Jiangming2, Xi Chunsheng1()
Received:
2024-09-10
Revised:
2024-10-25
Online:
2024-12-08
Published:
2025-01-07
Contact:
Xi Chunsheng
E-mail:chunshxi@sina.com
Supported by:
Li Tian, Wu Yang, Zhang Jiangming, Xi Chunsheng. Construction of a nomogram prediction model for lung metastasis in elderly patients with clear cell renal cell carcinoma[J]. Journal of International Oncology, 2024, 51(12): 755-762.
"
一般临床资料 | 肺转移患者 (n=620) | 无肺转移患者 (n=7 563) | χ²值 | P值 |
---|---|---|---|---|
年龄(岁) | ||||
60~64 | 162 | 1 701 | 6.27 | 0.280 |
65~69 | 150 | 1 863 | ||
70~74 | 132 | 1 704 | ||
75~79 | 94 | 1 164 | ||
80~84 | 42 | 657 | ||
≥85 | 40 | 474 | ||
种族 | ||||
黑种人 | 32 | 565 | ||
白种人 | 512 | 6 163 | 5.04 | 0.081 |
其他 | 76 | 835 | ||
性别 | ||||
女 | 192 | 2 721 | 6.27 | 0.012 |
男 | 428 | 4 842 | ||
婚姻状况 | ||||
单身 | 90 | 1 054 | 0.16 | 0.689 |
已婚 | 530 | 6 509 | ||
肿瘤最大径(mm) | ||||
<55 | 90 | 5 190 | ||
55~95 | 245 | 1 766 | 1 077.69 | <0.001 |
>95 | 285 | 607 | ||
T分期 | ||||
T1 | 115 | 5 301 | 850.38 | <0.001 |
T2 | 153 | 483 | ||
T3 | 284 | 1 669 | ||
T4 | 68 | 110 | ||
N分期 | ||||
N0 | 397 | 7 319 | 1 141.53 | <0.001 |
N1 | 223 | 244 | ||
临床分期 | ||||
Ⅰ | 0 | 5 134 | 4 369.92 | <0.001 |
Ⅱ | 0 | 405 | ||
Ⅲ | 0 | 1 555 | ||
Ⅳ | 620 | 469 | ||
手术情况 | ||||
否 | 446 | 1 724 | 710.11 | <0.001 |
是 | 174 | 5 839 |
"
一般临床资料 | 训练集(n=5 728) | 验证集(n=2 455) | χ²值 | P值 |
---|---|---|---|---|
年龄(岁) | ||||
60~64 | 1 294 | 569 | 1.58 | 0.903 |
65~69 | 1 404 | 609 | ||
70~74 | 1 291 | 545 | ||
75~79 | 879 | 379 | ||
80~84 | 489 | 210 | ||
≥85 | 371 | 143 | ||
种族 | ||||
黑种人 | 415 | 182 | ||
白种人 | 4 678 | 1 997 | 0.13 | 0.939 |
其他 | 635 | 276 | ||
性别 | ||||
女 | 2 023 | 890 | 0.66 | 0.418 |
男 | 3 705 | 1 565 | ||
婚姻状况 | ||||
单身 | 790 | 354 | 0.56 | 0.453 |
已婚 | 4 938 | 2 101 | ||
肿瘤最大径(mm) | ||||
<55 | 3 684 | 1 596 | ||
55~95 | 1 410 | 601 | 0.63 | 0.728 |
>95 | 634 | 258 | ||
T分期 | ||||
T1 | 3 786 | 1 630 | 3.10 | 0.377 |
T2 | 464 | 172 | ||
T3 | 1 355 | 598 | ||
T4 | 123 | 55 | ||
N分期 | ||||
N0 | 5 417 | 2 299 | 2.73 | 0.098 |
N1 | 311 | 156 | ||
临床分期 | ||||
Ⅰ | 3 601 | 1 533 | 2.97 | 0.396 |
Ⅱ | 297 | 108 | ||
Ⅲ | 1 077 | 478 | ||
Ⅳ | 753 | 336 | ||
手术情况 | ||||
否 | 1 534 | 636 | 0.67 | 0.412 |
是 | 4 194 | 1 819 |
"
因素 | OR值 | 95%CI | P值 |
---|---|---|---|
年龄(岁) | |||
60~64 | 1.00 | Reference | |
65~69 | 0.80 | 0.60~1.05 | 0.106 |
70~74 | 0.82 | 0.62~1.08 | 0.157 |
75~79 | 0.84 | 0.61~1.15 | 0.269 |
80~84 | 0.66 | 0.44~1.01 | 0.053 |
≥85 | 0.93 | 0.61~1.40 | 0.716 |
种族 | |||
黑种人 | 1.00 | Reference | |
白种人 | 1.58 | 1.01~2.49 | 0.046 |
其他 | 1.85 | 1.10~3.10 | 0.020 |
性别 | |||
女 | 1.00 | Reference | |
男 | 1.32 | 1.07~1.64 | 0.009 |
婚姻状况 | |||
单身 | 1.00 | Reference | |
已婚 | 0.92 | 0.70~1.21 | 0.562 |
肿瘤最大径(mm) | |||
<55 | 1.00 | Reference | |
55~95 | 8.22 | 6.11~11.07 | <0.001 |
>95 | 28.12 | 20.81~37.99 | <0.001 |
T分期 | |||
T1 | 1.00 | Reference | |
T2 | 15.62 | 11.51~21.19 | <0.001 |
T3 | 7.93 | 6.06~10.36 | <0.001 |
T4 | 28.65 | 18.71~43.86 | <0.001 |
N分期 | |||
N0 | 1.00 | Reference | |
N1 | 17.18 | 13.36~22.10 | <0.001 |
手术情况 | |||
否 | 1.00 | Reference | |
是 | 0.12 | 0.09~0.14 | <0.001 |
"
因素 | OR值 | 95%CI | P值 | |
---|---|---|---|---|
种族 | ||||
黑种人 | 1.00 | Reference | ||
白种人 | 1.82 | 1.07~3.09 | 0.027 | |
其他 | 2.18 | 1.17~4.05 | 0.014 | |
性别 | ||||
女 | 1.00 | Reference | ||
男 | 1.15 | 0.89~1.48 | 0.290 | |
肿瘤最大径(mm) | ||||
<55 | 1.00 | Reference | ||
55~95 | 4.63 | 3.13~6.86 | <0.001 | |
>95 | 8.29 | 5.28~13.02 | <0.001 | |
T分期 | ||||
T1 | 1.00 | Reference | ||
T2 | 2.26 | 1.45~3.51 | <0.001 | |
T3 | 3.38 | 2.28~5.01 | <0.001 | |
T4 | 2.45 | 1.39~4.31 | 0.002 | |
N分期 | ||||
N0 | 1.00 | Reference | ||
N1 | 3.81 | 2.81~5.17 | <0.001 | |
手术情况 | ||||
否 | 1.00 | Reference | ||
是 | 0.10 | 0.08~0.14 | <0.001 |
[1] | Liu Y, Qi L, Ye B, et al. MOICS, a novel classier deciphering immune heterogeneity and aid precise management of clear cell renal cell carcinoma at multiomics level[J]. Cancer Biol Ther, 2024, 25(1): 2345977. DOI: 10.1080/15384047.2024.2345977. |
[2] | Siegel RL, Miller KD, Wagle NS, et al. Cancer statistics, 2023[J]. CA Cancer J Clin, 2023, 73(1): 17-48. DOI: 10.3322/caac.21763. |
[3] | Rizzo A, Mollica V, Santoni M, et al. Impact of clinicopathological features on survival in patients treated with first-line immune checkpoint inhibitors plus tyrosine kinase inhibitors for renal cell carcinoma: a meta-analysis of randomized clinical trials[J]. Eur Urol Focus, 2022, 8(2): 514-521. DOI: 10.1016/j.euf.2021.03.001. |
[4] | Wei H, Miao J, Cui J, et al. The prognosis and clinicopathological features of different distant metastases patterns in renal cell carcinoma: analysis based on the SEER database[J]. Sci Rep, 2021, 11(1): 17822. DOI: 10.1038/s41598-021-97365-6. |
[5] | Yi X, Zhang Y, Cai J, et al. Development and external validation of machine learning-based models for predicting lung metastasis in kidney cancer: a large population-based study[J]. Int J Clin Pract, 2023, 2023: 8001899. DOI: 10.1155/2023/8001899. |
[6] | Rebuzzi SE, Fornarini G, Signori A, et al. Banana-shaped survival curves of metastatic renal cell carcinoma treated with first-line immune-combinations, not just a matter of "palateau"[J]. Hum Vaccin Immunother, 2024, 20(1): 2351669. DOI: 10.1080/21645515.2024.2351669. |
[7] | 伍杨, 李甜, 史婷婷, 等. 老年肝细胞癌患者总生存期的影响因素及预后列线图预测模型构建: 一项基于人群的研究[J]. 肿瘤防治研究, 2024, 51(9): 756-763. DOI: 10.3971/j.issn.1000-8578.2024.24.0009. |
[8] | Berben L, Floris G, Kenis C, et al. Age-related remodelling of the blood immunological portrait and the local tumor immune response in patients with luminal breast cancer[J]. Clin Transl Immunology, 2020, 9(10): e1184. DOI: 10.1002/cti2.1184. |
[9] | Lu Z, He W, Zhou J, et al. Construction and validation of a novel prognostic nomogram for patients with metastatic renal cell carcinoma: a SEER-based study[J]. J Int Med Res, 2022, 50(6): 3000605221105367. DOI: 10.1177/03000605221105367. |
[10] | Dai L, Pan D, Jin J, et al. A novel immune-related lncRNA signature predicts the prognosis and immune landscape in ccRCC[J]. Aging (Albany NY), 2024, 16(6): 5149-5162. DOI: 10.18632/aging.205633. |
[11] | Schmeusser BN, Patil DH, Nicaise EH, et al. 2018 Leibovich prognostic model for renal cell carcinoma: performance in a large population with special consideration of Black race[J]. Cancer, 2024, 130(3): 453-466. DOI: 10.1002/cncr.35037. |
[12] | Tong Y, Huang Z, Hu C, et al. Construction and validation of a convenient clinical nomogram to predict the risk of brain metastasis in renal cell carcinoma patients[J]. Biomed Res Int, 2020, 2020: 9501760. DOI: 10.1155/2020/9501760. |
[13] | Hua KC, Hu YC. Establishment of predictive model for patients with kidney cancer bone metastasis: a study based on SEER database[J]. Transl Androl Urol, 2020, 9(2): 523-543. DOI: 10.21037/tau.2020.01.24. |
[14] |
Mao W, Fu Z, Wang K, et al. Prognostic nomogram for patients with lung metastatic renal cell carcinoma: a SEER-based study[J]. Ann Palliat Med, 2021, 10(3): 2791-2804. DOI: 10.21037/apm-20-1488.
pmid: 33549017 |
[15] | Dudani S, de Velasco G, Wells JC, et al. Evaluation of clear cell, papillary, and chromophobe renal cell carcinoma metastasis sites and association with survival[J]. JAMA Netw Open, 2021, 4(1): e2021869. DOI: 10.1001/jamanetworkopen.2020.21869. |
[16] | Deng J, Tu S, Li L, et al. Diagnostic, predictive and prognostic molecular biomarkers in clear cell renal cell carcinoma: a retrospective study[J]. Cancer Rep (Hoboken), 2024, 7(6): e2116. DOI: 10.1002/cnr2.2116. |
[17] |
Zhuang W, Chen J, Li Y, et al. Valuation of lymph node dissection in localized high-risk renal cell cancer using X-tile software[J]. Int Urol Nephrol, 2020, 52(2): 253-262. DOI: 10.1007/s11255-019-02307-x.
pmid: 31612422 |
[18] | 王鹏, 江涛, 张文凤, 等. 减瘤性肾切除术联合舒尼替尼治疗肾癌合并肺转移患者的疗效与安全性[J]. 中国煤炭工业医学杂志, 2023, 26(2): 128-133. DOI: 10.11723/mtgyyx1007-9564 202302004. |
[19] | 周园, 郑建坤, 郭立仪, 等. 基于SEER数据库探讨原发灶减瘤术对老年转移性肾透明细胞癌患者预后的影响[J]. 广州医科大学学报, 2022, 50(2): 24-29. DOI: 10.3969/j.issn.2095-9664.2022.02.04. |
[20] | Nishimura T, Katsumori T, Yoshikawa T, et al. Hemoptysis due to a lung metastasis of renal cell carcinoma: a case report[J]. Radiol Case Rep, 2023, 18(3): 1073-1075. DOI: 10.1016/j.radcr.2022.12.007. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||